BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34876291)

  • 1. From street address to survival: Neighborhood socioeconomic status and pancreatic cancer outcomes.
    Eskander MF; Hamad A; Li Y; Fisher JL; Oppong B; Obeng-Gyasi S; Tsung A
    Surgery; 2022 Mar; 171(3):770-776. PubMed ID: 34876291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory breast cancer, trimodal treatment, and mortality: Does where you live matter?
    Relation T; Li Y; Fisher JL; Tsung A; Oppong B; Eskander MF; Obeng-Gyasi S
    Surgery; 2022 Mar; 171(3):687-692. PubMed ID: 34857388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The implications of neighborhood socioeconomic status on surgical management and mortality in malignant phyllodes patients in the Surveillance, Epidemiology, and End Results program.
    Obeng-Gyasi S; Bhattacharyya O; Li Y; Eskander M; Tsung A; Oppong B
    Surgery; 2020 Dec; 168(6):1122-1127. PubMed ID: 32847674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of socioeconomic status on presentation, treatment and outcomes of patients with pancreatic cancer.
    Abdel-Rahman O
    J Comp Eff Res; 2020 Dec; 9(17):1233-1241. PubMed ID: 33275039
    [No Abstract]   [Full Text] [Related]  

  • 5. Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapy.
    Kasumova GG; Eskander MF; de Geus SWL; Neto MM; Tabatabaie O; Ng SC; Miksad RA; Mahadevan A; Rodrigue JR; Tseng JF
    Surgery; 2017 Aug; 162(2):275-284. PubMed ID: 28487044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis.
    Amin S; Lucas AL; Frucht H
    Pancreas; 2013 Mar; 42(2):249-53. PubMed ID: 22836862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of depression on stage at diagnosis, treatment, and survival in pancreatic adenocarcinoma.
    Boyd CA; Benarroch-Gampel J; Sheffield KM; Han Y; Kuo YF; Riall TS
    Surgery; 2012 Sep; 152(3):403-13. PubMed ID: 22938900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment choices and outcomes of non-metastatic hepatocellular carcinoma patients in relationship to neighborhood socioeconomic status: a population-based study.
    Abdel-Rahman O
    Int J Clin Oncol; 2020 May; 25(5):861-866. PubMed ID: 31953780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
    Shapiro M; Chen Q; Huang Q; Boosalis VA; Yoon CH; Saund MS; Whang EE; Gold JS
    JAMA Surg; 2016 Apr; 151(4):338-45. PubMed ID: 26581025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of socioeconomic status on survival in stage III colon cancer patients: A retrospective cohort study using the SEER census-tract dataset.
    Dhahri A; Kaplan J; Naqvi SMH; Brownstein NC; Ntiri SO; Imanirad I; Felder SI; Dineen SP; Sanchez J; Dessureault S; Carballido E; Powers BD
    Cancer Med; 2021 Aug; 10(16):5643-5652. PubMed ID: 34197047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
    Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
    Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in utilization of treatment for clinical stage I-II pancreatic adenocarcinoma by area socioeconomic status and race/ethnicity.
    Swords DS; Mulvihill SJ; Brooke BS; Skarda DE; Firpo MA; Scaife CL
    Surgery; 2019 Apr; 165(4):751-759. PubMed ID: 30551868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the clinical presentation, treatment, and survival for pancreatic adenocarcinoma.
    Salami A; Obaid T; Joshi ART
    Am J Surg; 2019 Jan; 217(1):103-107. PubMed ID: 29807632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Treatment Patterns and Survival Outcomes in Elderly Pancreatic Cancer Patients: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
    Shaib WL; Jones JS; Goodman M; Sarmiento JM; Maithel SK; Cardona K; Kane S; Wu C; Alese OB; El-Rayes BF
    Oncologist; 2018 Jun; 23(6):704-711. PubMed ID: 29445028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of socioeconomic status on survival for patients with anal cancer.
    Lin D; Gold HT; Schreiber D; Leichman LP; Sherman SE; Becker DJ
    Cancer; 2018 Apr; 124(8):1791-1797. PubMed ID: 29527660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008.
    Worni M; Guller U; White RR; Castleberry AW; Pietrobon R; Cerny T; Gloor B; Koeberle D
    Pancreas; 2013 Oct; 42(7):1157-63. PubMed ID: 23867367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
    Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
    Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
    Stessin AM; Meyer JE; Sherr DL
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.